six sigma and pharmaceutical industry4
TRANSCRIPT
11
Quality Horizons First Annual ForumQuality in Healthcare
Under the patronage of His Excellency
Eng. Saeed DarwazahMinister of Health – Hashemite Kingdom of Jordan
Amman - April 2006
Quality Horizons
Towards Excellence in Health ServicesTowards Excellence in Health Services
22
ContinuousAvailability
OperationalSimplicity
FinancialAdvantage
Abdulaziz Saddique Pharm.D., CPHQ, CSSBB
Certified Six Sigma Master Black Belt
33
ContentsContents
• Why Pharmaceutical Industry
• Pharmaceutical Product life cycle• Dimensions of the FDA’s Initiative on Pharmaceutical
Quality for the 21st Century
• Quality Tools (TQM, Six Sigma etc.)
44
Why Pharmaceutical Industry?Why Pharmaceutical Industry?• Deals with vital
Products• Life Saving• Perfection is essential• Generics Market is
progressing rapidly• Variability is the main
problem with Generics
55
Launch & Manufacture
Lead Selection
Pre Clinical
Phase I Phase IIIReg.
ReviewPhase II
8-10 yrs
Patent Exclusivity ( 20 yrs )
Pharma Product Life CyclePharma Product Life Cycle
2 yrs
• Start Earlier, Finish Later•‘Receiver’ to ‘Co-Creator’• Must Have Clear Competitive Advantage over Sister Sites
5 yrs 5 yrs
Traditional ManufacturingStart Earlier
Finish Later
66
Dimensions of the FDA’s Initiative on Dimensions of the FDA’s Initiative on Pharmaceutical Quality for the 21Pharmaceutical Quality for the 21stst Century Century
FDA Unveils New Initiative To Enhance Pharmaceutical Good Manufacturing Practices
Strong Public Health
Protection
Integrated quality systems orientation
Science-based policies and standards
Risk-based orientation
International cooperation
Time
77
Dimensions of Pharmaceutical Quality Dimensions of Pharmaceutical Quality for the 21for the 21stst Century Century
• FDA initiatives – cGMP – Process Analytical Technology (PAT)– ICH
• Quality tools– TQM– Six Sigma– Fusion Management
88
99
Pharmaceutical cGMP’s for the 21Pharmaceutical cGMP’s for the 21stst CenturyCentury
• A science and risk-based approach to product quality regulation incorporating an integrated quality approach– incorporate most up-to-date concepts of risk
management and scientific advances
– encourage innovation and continuous improvement
– ensure that submission review and cGMP inspection are coordinated and synergistic
– consistency and systems effective utilization of resources
1010
Pharmaceutical cGMP’s for the 21Pharmaceutical cGMP’s for the 21stst CenturyCentury
• Guiding Principles– Risk-based orientation
– Science-based policies and standards
– Integrated quality systems orientation
– International cooperation
– Strong Public Health Protection
1111
Product and Process Quality Product and Process Quality KnowledgeKnowledge: : Science-Risk Based cGMP’sScience-Risk Based cGMP’s
Quality by DesignProcess Design
Yes, Limited to theExperimentalDesign Space
Maybe, Difficult toAssesses
GMP/CMC FOCUS Design qualification
Focused; Critical Process Control Points (PAT)
Extensive; EveryStep (CURRENT)
DATA DERIVED FROM
TRIAL-N-ERROR EXPERIMENTATION
DECISIONS BASED ONUNIVARIATE APPROACH
CAUSAL LINKSPREDICT PERFORMANCE
MECHANISTICUNDERSTANDING
1st Principles
1212
1313
What is PATWhat is PAT
PAT is the Food and Drug Administration - Center for Drug Evaluation and Research's model for
developing a regulatory framework to facilitate introduction of new manufacturing technologies
that enhance process efficiencies.
1414
What is PATWhat is PAT
Scientific principles and tools supporting innovation
• PAT Principles– Process Understanding – Risk-Based Approach– Regulatory Strategy to accommodate innovation– Real Time Release
• PAT Tools– Multivariate Tools for Design, Data Acquisition and Analysis (Six Sigma)– Process Analyzers (Six Sigma)– Process Control Tools (Six Sigma)– Continuous Improvement and Knowledge Management Tools (KAIZEN,
TQM, Lean Processing)
1515
PAT: Conceptual FrameworkPAT: Conceptual Framework
IncomingMaterials.
SpecificationsRelevant to
“Process-ability”
Incoming material attributesused to predict/adjust
optimal processing parameterswithin established bounds
(more flexible bounds)
PACPACPACPAC
PACPAC
PCCPPCCP
LTLTCMCMITIT
Direct or inferentialassessment of quality
and performance (at/on-line)
Control of process criticalcontrol points (PCCP).
Process end point (PEPs’) rangebased on “performance” attributes.
PEP’s
Chemometrics (CM)and IT Tools
for “real time”control and decisions
At-lineIn/On-Line
Process AnalyticalChemistry Tools Laboratory
or othertests
LTLT
Development/Optimization/Continuous Improvement (DOE, Evolutionary optimization, Improved efficiency)
MultivariateSystems Approach
RiskClassificationand MitigationStrategies
1616
1717
International Conference on International Conference on Harmonization (ICH)Harmonization (ICH)
• The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) is a unique project that brings together the regulatory authorities of Europe, Japan and the United States and experts from the pharmaceutical industry in the three regions to discuss scientific and technical aspects of product registration.
• The purpose is to make recommendations on ways to achieve greater harmonization in the interpretation and application of technical guidelines and requirements for product registration in order to reduce or obviate the need to duplicate the testing carried out during the research and development of new medicines.
1818
Continuous Improvement – Emerging ICH Continuous Improvement – Emerging ICH Q8 “Design Space” ConceptQ8 “Design Space” Concept
• Multi-dimensional space defined by critical vectors of product quality and performance
– Examples of critical vectors
» Robust manufacturing process – consistent, reproducible delivery of product meeting its specifications
• Manufacturing options
» Stability (shelf-life) and
» Bioavailability
1919
Knowledge based decisions: Improved Knowledge based decisions: Improved Ability to Generalize Ability to Generalize
Pharmaceutical Development Knowledge
environmental
raw material properties
process conditions
Robust process
Stable and Bioavailable product
2020
Process Understanding
Post approval change
Risk
CMC regulatory oversight
Company’sQuality system
cGMP regulatory oversight
ICH Q8
ICH Q8&9ICH Q8&9
2121
Process Understanding
Risk
CMC regulatory oversight
Company’sQuality system
cGMP regulatory oversight
Post approval change
ContinuousImprovement
Process Understanding
Risk
CMC regulatory oversight
Company’sQuality system
cGMP regulatory oversight
PAC to Continuous
Improvement
Process Understanding
Risk
CMC regulatory oversight
Company’sQuality system
cGMP regulatory oversight
ICH Q8 + Q9 ProposedICH Q 10
2222
Quality Programs IntegrationQuality Programs Integration
2323
1900 1918 1937 1960 1980
Operator
Foreman
Inspection
Statistical
Total Quality Control
EvolutionSix Sigma
"Real assurance of quality today requires far more than good intentions, testing and inspection activities, and a traditional quality-control department. It takes the same business, managerial, and technical depth to assure the quality and quality cost of a product as it does to design, make, sell, and service the product itself - depth that starts well before production begins and ends only with a satisfied customer."
A. V. Feigenbaum. Total Quality Control. 3rd Ed., McGraw-Hill, 1983
PAT enables
QC Evolution
2424
2525
What is Six Sigma?… What is Six Sigma?… Methodology for achieving goals and
objectives
Quantitative technique for problem solving
Comprehensive improvement process
Tools For Driving Sustainable Change
2626
What is six sigma?What is six sigma?
You’ll be able to: • Identify what % of revenue (approximate) is lost to poor quality at
3,4,5 & 6 sigma levels? • Explain the Success/Change Formula. • Identify the yield and DPMO at 4 sigma. • Explain the differences between Six Sigma and TQM? • Explain Customer Critical Criteria. • Explain three different meanings used for Six Sigma? • Explain the elements of the Scientific Method. • Define SIPOC
– Explain each component • Define DMAIC?
– Explain each component • List and discuss the seven core competencies for Six Sigma Plus.
2727
Solid tools but….Solid tools but….
• Quality tool
• Vague goals
• No standard metrics
• Open-ended, unstructured
• Department-based
• Focus on product quality
Real results that matter to Real results that matter to customers….customers….
• Business tool
• Clear goals/deliverables
• Clear, consistent metrics
• Rigorous timeline
• Business-based
• Focus on customer
Six Sigma builds on Lessons Learned from prior approaches
TQM Six Sigma
What Makes Six Sigma Different?Adapted with permission from Hamadi Said, US Mint Philadelphia, PA
2828
The Nature of VariationThe Nature of Variation
. . . So how does this principletranslate into the real world?
Mean is Centered ( it is On Target), but
there is Large Variation (Big Sigma!)
Mean is Centered ( it is On Target), but
there is Large Variation (Big Sigma!)
Accurate but not Precise
Mean is not Centered ( it is Off Target);
the Variation is Small
Mean is not Centered ( it is Off Target);
the Variation is Small
Precise but not Accurate
2929
Six Sigma is… A Six Sigma is… A QuantitativeQuantitative MethodologyMethodology
Sigma = Standard Deviation
Goal: Eliminate Defects
“Move the Mean…Reduce Variability”
1
2
3
TargetCustomer
Spec
36.6% Defects
Today
1
36
Target
No Defects!
Desired State
6
2 308,537
3 66,807
4 6,210
5 233
6 3.4
DPMO
Y= f(X1+X2+X3+…..Xn)
3030
Six SigmaSix Sigma Many aspects of the industry have
adopted Six Sigma. Both PAT and 6are process oriented approaches to achieving efficiencies, reduced cycle time and improved quality
3131
What “Six Sigma” MeansWhat “Six Sigma” Means
As the process capability improves, defects become less and less likely
-3
+3
Cp = 1.00
-4
+4
Cp = 1.33
-5
+5
Cp = 1.67
-6
+6
Cp = 2.00Cp = 0.67
-2
+2
USL
LSL
3232
Achieving RobustnessAchieving Robustness
At 6, even process upsets do not produce defects
308,540 ppm66807 ppm
6210 ppm233 ppm 3.4 ppm
+2
Cp = 0.67
+3
Cp = 1.00
+4
Cp = 1.33
+5
Cp = 1.67
+6
Cp = 2.00
USL
LSL
3333
Six Sigma: Ambitious Objective?
Near Perfection 99.99966 % = 6.0 σ, less than 3.4 defects per million opportunities, sounds excessive!!!
Why isn’t 99.9% already GOOD ENOUGH in our everyday lives (or 1000 ppm or 4.6σ)?
It would mean:
4000 wrong medical prescriptions each yearMore than 3000 newborns accidentally falling from the hands of nurses or doctors each yearTwo long or short landings at Chicago airport each day
400 letters per hour would never arrive at their destination
3434
Why Six Sigma?Why Six Sigma?
Define Measure Analyze Design Verify
Define Measure Analyze Improve Control
• Six Sigma embraces both continuous improvement and breakthrough performance. The process includes models for manufacturing, design and administrative services
Design For Six Sigma (DFSS)
Manufacturing & Administrative
3535
Covering the Space Defined by the Covering the Space Defined by the Directional VectorsDirectional Vectors
Risk
Science
Pre-approval Inspection Compliance Program
Dispute Resolution Process
Process Perfection
PATPAT
Pharmaceutical Inspectorate
Product Specialists on Inspection Process
Comparability Protocol
Aseptic Procesing
Syste
ms/In
tegra
tion
ICH P2, QbD, & RiskICH P2, QbD, & Risk
IntegrationFusion
Management
3636
Fusion ManagementFusion ManagementTMTM
A tool for fusing PAT and Six Sigma, TQM, KAIZEN, Lean, Performance Excellence and
Management Systems to overcome the existing constraints
3737
The Quality Systems Opportunity The Quality Systems Opportunity A Historical Note on Quality: Milestones in Quality Journey or A Historical Note on Quality: Milestones in Quality Journey or
Lurching from Fad to Fad?Lurching from Fad to Fad?
• Sampling Plans (‘50s)
• Zero-Defect Movement (‘60s)
• ISO-9000 (‘80s)
• QS-9000
• Malcolm Baldrige Award
• European Quality Award
• Total Quality Management
• Six Sigma– The Ultimate Six Sigma - “The Big Q”
cGMPs
K. R. Bhote and A. K. Bhote. World Class Quality (2000) ISBN 0-8144-0427
PharmaceuticalQualitySystem
for the 21st
Century
3838
Generics PharmaceuticalsGenerics Pharmaceuticals
• Problems Discussed with Generics– Poor Activity– Variability– Poor Quality– Adverse Reactions– Instability
3939
Desired StateDesired State
Product quality and performance achieved and assured by design of effective and efficient manufacturing processes
Product specifications based on mechanistic understanding of how formulation and process factors impact product performance
Continuous "real time" assurance of quality
4040
Desired StateDesired State
Regulatory policies tailored to recognize the level of scientific knowledge supporting product applications, process validation, and process capability
Risk based regulatory scrutiny relate to the: level of scientific understanding of how formulation
and manufacturing process factors affect product quality and performance, and
the capability of process control strategies to prevent or mitigate risk of producing a poor quality product
4141
FinallyFinally
Integrated Six Sigma (Fusion Management) is the answer to Process Perfection, overall
quality assurance, the most efficient system for Cost Saving, Waste elimination and continual improvement of your products
and services.
4242
How How Machiavellian … Machiavellian …
"Whoever "Whoever desires desires constant constant success must success must change his change his conduct with conduct with the times."the times."
4343
How How Machiavellian … Machiavellian … "There is nothing more "There is nothing more difficult to take in hand, more difficult to take in hand, more perilous to conduct, or more perilous to conduct, or more uncertain in its success, than uncertain in its success, than to take the lead in the to take the lead in the introduction of a new order of introduction of a new order of things. Because the innovator things. Because the innovator has for enemies all those who has for enemies all those who have done well under the old have done well under the old conditions, and lukewarm conditions, and lukewarm (indifferent, uninterested) (indifferent, uninterested) defenders in those who may defenders in those who may do well under the new. "do well under the new. "
CIO
4444